Andreas Kogelnik

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Jump to: navigation, search
Source: www.openmedicinefoundation.org

Andreas M. Kogelnik, ("Andy") MD, PhD., is an Internal Medicine and Infectious Diseases specialist, the director of the Open Medicine Institute, Mountain View, California, USA, and a member of the Scientific Advisory Board for the Open Medicine Foundation, Agoura Hills, CA.[1][2] His interests are in the bioinformatics and genomic revolution in medicine and is committed to the study of and treatment of ME/CFS and other chronic illnesses.[3][4]

Education[edit]

  • MD from Emory University
  • PhD in bioengineering from Georgia Tech
  • Residency in Internal Medicine at Stanford University
  • Fellowship in Infectious Diseases at Stanford University

Research Publications on ME/CFS[edit]

  • 2013, Randomized clinical trial to evaluate the efficacy and safety of valganciclovir in a subset of patients with chronic fatigue syndrome.[5]
  • 2011, No evidence of murine-like gammaretroviruses in CFS patients previously identified as XMRV-infected.[6]
  • 2006, Use of valganciclovir in patients with elevated antibody titers against Human Herpesvirus-6 (HHV-6) and Epstein-Barr Virus (EBV) who were experiencing central nervous system dysfunction including long-standing fatigue.[7]

Articles[edit]

Talks and Interviews[edit]

References[edit]

  1. http://www.openmedicineinstitute.org/the-clinic.html
  2. http://www.openmedicinefoundation.org/scientific-advisory-board/
  3. http://www.openmedicineinstitute.org/the-clinic.html
  4. http://www.openmedicinefoundation.org/scientific-advisory-board/
  5. Montoya JG, Kogelnik AM, Bhangoo M, Lunn MR, Flamand L, Merrihew LE, Watt T, Kubo JT, Paik J, Desai M.(2013). Randomized clinical trial to evaluate the efficacy and safety of valganciclovir in a subset of patients with chronic fatigue syndrome. Journal of Medical Virology,85 (12):2101-9. doi: 10.1002/jmv.23713. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/23959519
  6. Knox K, Carrigan D, Simmons G, Teque F, Zhou Y, Hackett J Jr, Qiu X, Luk KC, Schochetman G, Knox A, Kogelnik AM, Levy JA.(2011). No evidence of murine-like gammaretroviruses in CFS patients previously identified as XMRV-infected. Science,333 (6038):94-7. doi: 10.1126/science.1204963. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/21628393
  7. Kogelnik AM, Loomis K, Hoegh-Petersen M, Rosso F, Hischier C, Montoya JG. Use of valganciclovir in patients with elevated antibody titers against Human Herpesvirus-6 (HHV-6) and Epstein-Barr Virus (EBV) who were experiencing central nervous system dysfunction including long-standing fatigue. Journal of Clinical Virology,37 Suppl 1:S33-8. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed /17276366


The information provided at this site is not intended to diagnose or treat any illness.

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history